Former heavyweight champion Joseph Parker has maintained that the positive drug test which led to his suspension from boxing was not the result of his own actions, but rather stemmed from exposure to cocaine used by his nutritionist, according to a statement from UK Anti-Doping (UKAD). The New Zealand-born boxer tested positive for benzoylecgonine, a metabolite that indicates cocaine consumption, after a routine UKAD screening conducted shortly after his unexpected loss to Fabio Wardley in London on 25 October 2025. Parker, who has consistently denied any personal use of prohibited substances throughout the investigation, announced on Wednesday that the provisional ban—potentially as long as two years—had been lifted, and that he intends to return to the ring in the near future. The following day, UKAD officially confirmed that Parker was cleared to resume his boxing career, releasing details that included the 34‑year‑old’s explanation for the adverse analytical finding (AAF).
In a formal UKAD communiqué, the agency detailed the timeline of events: "On 6 March 2026, Mr Parker supplied UKAD with documentation asserting that the AAF was the consequence of his exposure to cocaine used by the nutritionist he employed in preparation for the 25 October 2025 bout. The nutritionist admitted to being a regular cocaine user and confirmed daily use during the week leading up to the fight. Between 14 April 2026 and 3 June 2026, UKAD requested additional information from Mr Parker regarding his explanation. Parker disclosed that he had first begun working with the same nutritionist in April 2023." UKAD explained that after reviewing the evidence, it decided to impose a three‑month period of ineligibility, which it considered already served, because an independent scientific expert concluded that any cocaine ingestion had occurred out of competition and therefore was unrelated to Parker’s sporting performance.
The statement continued: "On 15 June 2026, UKAD received an independent scientific expert opinion which concluded that Mr Parker's ingestion of cocaine most likely took place out of competition (i.e., before 11:59 pm on 24 October 2025). On 22 June 2026, UKAD confirmed to Mr Parker that, in light of the expert’s opinion, it was satisfied that any ingestion of cocaine occurred out of competition and thus was unrelated to sport performance. Consequently, UKAD lifted Mr Parker's provisional suspension on that date, allowing him to resume participation in sport immediately, and proposed a three‑month period of ineligibility (deemed served) as the sanction for his anti‑doping rule violation." The expert’s report also noted the possibility that Parker’s positive result could have arisen from contamination rather than deliberate consumption.
"It is also my opinion that Mr Parker's administration of cocaine may have occurred orally from food contaminated with cocaine by his sports nutritionist, who has admitted being a user of cocaine, giving rise to the finding of benzoylecgonine in Mr Parker's urine samples," the expert wrote. "I cannot exclude the possibility that the finding of benzoylecgonine has arisen as the tail end of the administration of a larger pharmacologically active dose of cocaine." As a result of the anti‑doping ruling, Parker’s loss to Wardley, originally recorded as an 11th‑round stoppage victory for the British fighter, has been re‑classified as a defeat by disqualification rather than a knockout. The outcome has significant implications for Parker’s record and future title opportunities.
Parker’s career trajectory has been marked by notable highs and lows. He captured the heavyweight world title in 2018 by defeating Anthony Joshua, a triumph that cemented his status among the sport’s elite. After a setback against Joe Joyce in 2022, Parker rebounded impressively, stringing together six consecutive wins, including statement victories over former champion Deontay Wilder and Chinese contender Zhilei Zhang, and securing the WBO interim belt. He was slated to challenge IBF champion Daniel Dubois in February, but the bout was cancelled when Dubois fell ill shortly before the scheduled date.
Undeterred, Parker accepted a high‑stakes fight against WBO mandatory challenger Fabio Wardley, a decision that placed his mandatory challenger position for undisputed champion Oleksandr Usyk at risk. The gamble did not pay off, as Wardley stopped Parker in the eleventh round, a result now overturned to a disqualification loss.
Looking ahead, Parker’s reinstatement by UKAD opens the door for him to re‑enter the heavyweight division’s competitive landscape. The lifting of his provisional suspension means he can train, compete, and pursue another title shot without further delay.
However, the shadow of the doping case—and the unusual circumstance of alleged contamination via a nutritionist’s drug use—adds a complex layer to his public image and future negotiations. The broader boxing community has taken note of the case, highlighting the importance of athletes monitoring not only their own substance intake but also that of any support personnel. Anti‑doping agencies emphasize that athletes bear ultimate responsibility for any prohibited substances found in their bodies, regardless of the source.
Parker’s situation underscores the challenges of navigating these strict liability rules, especially when contamination or indirect exposure is alleged. In summary, Joseph Parker’s positive test for a cocaine metabolite has been attributed to exposure through a nutritionist who admitted regular cocaine use.
An independent expert concluded the ingestion likely occurred out of competition, leading UKAD to deem the three‑month sanction served and to lift his provisional ban. With his suspension removed, Parker is poised to return to the ring, aiming to rebuild his reputation and chase further heavyweight glory, while the incident serves as a cautionary tale about the far‑reaching implications of anti‑doping regulations in professional sport.